Liver disease, HT and thromboembolic risk, cancer screenings, and septic shock
This week's topics include lean metabolic associated liver disease, HT and thromboembolic risk, blood-based cancer screening impact, and best strategy for early septic shock.
Program notes:
0:40 Lean metabolic associated liver disease
1:40 Biopsy confirmed MASLD
2:40 Elastography for diagnosis
3:41 Liver transplant often needed
4:04 HT and thromboembolic disease
5:04 VTE, ischemic stroke and MI
6:04 Oral estrogen increased risk
7:07 Liquid cancer biopsy impact
8:07 Not had cancer compared to routine screening
9:07 Not seeing a positive impact
10:05 Inter-interval breast cancers
10:31 How to manage early septic shock
11:31 Main outcome alive and out of the hospital at day 90
12:30 Both are equally effective
13:20 End